Fenbendazole Market
According to Intent Market Research, the Fenbendazole Market is expected to grow from USD 1.4 Billion in 2023 at a CAGR of 8.3% to touch USD 2.4 Billion by 2030. The Fenbendazole Market is dominated by key players such as Bayer AG, Ceva Sant? Animale, Elanco Animal Health, Hikma Pharmaceuticals, Huvepharma, Jiangsu Shengdi Pharmaceutical Co. Ltd., Liphatech, Inc., Merck & Co., Inc., Merial (acquired by Boehringer Ingelheim), Norbrook Laboratories Ltd., Trifecta Pharmaceuticals USA, Vetoquinol and Zoetis Inc.